dabigatran has been researched along with Lung Diseases, Interstitial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, YH; Chao, TF; Chen, SW; Chen, WM; Kuo, CT; Lee, HF; Li, PR; Lip, GYH; See, LC; Yeh, YH | 1 |
| Akter, T; Bogatkevich, GS; Ludwicka-Bradley, A; Nietert, PJ; Silver, RM; van Ryn, J | 1 |
2 other study(ies) available for dabigatran and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Lung Diseases, Interstitial; Male; Retrospective Studies; Taiwan; Warfarin | 2022 |
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Topics: Administration, Oral; Animals; Antithrombins; Benzimidazoles; beta-Alanine; Bleomycin; Dabigatran; Disease Models, Animal; Female; Lung Diseases, Interstitial; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Thrombin | 2011 |